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Abstract
Background: Hospital discharge codes are increasingly used in gastroenterology research, but their accuracy in the
setting of acute pancreatitis (AP) and chronic pancreatitis (CP), one of the most frequent digestive diseases, has never
been assessed systematically. The aim was to conduct a systematic literature review and determine accuracy of
diagnostic codes for AP and CP, as well as the effect of covariates.
Methods: Three databases (Pubmed, EMBASE and Scopus) were searched by two independent reviewers for relevant
studies that used International Classiﬁcation of Disease (ICD) codes. Summary estimates of sensitivity, speciﬁcity and
positive predictive value were obtained from bivariate random-effects regression models. Sensitivity and subgroup
analyses according to recurrence of AP and age of the study population were performed.
Results: A total of 24 cohorts encompassing 18,106 patients were included. The pooled estimates of sensitivity and
speciﬁcity of ICD codes for AP were 0.85 and 0.96, respectively. The pooled estimates of sensitivity and speciﬁcity of
ICD codes for CP were 0.75 and 0.94, respectively. The positive predictive value of ICD codes was 0.71 for either AP or
CP. It increased to 0.78 when applied to incident episode of AP only. The positive predictive value decreased to 0.68
when the ICD codes were applied to paediatric patients.
Conclusion: Nearly three out of ten patients are misidentiﬁed as having either AP or CP with the indiscriminate use of
ICD codes. Limiting the use of ICD codes to adult patients with incident episode of AP may improve identiﬁcation of
patients with pancreatitis in administrative databases.
Introduction
Advancements in information technology have revolu-
tionised the way individual patient data are collected and
processed1. Increasingly, more simultaneous documenta-
tion and execution has allowed large amounts of data to
be amassed in a short time2—a phenomenon that has
been penned 'big data'. 'Big data' is deﬁned by character-
istics of large variety of sources, volume and velocity3. In
the health industry, these sources can vary from regional
databases of electronic health records and cancer regis-
tries to individual smartphone monitoring of sleep and
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diet3. Digitalisation has enabled practical and low-cost
accessibility of ‘big data’, and one example of it is the use
of administrative diagnostic codes. Diagnostic coding is
now used ubiquitously, including application for the
purpose of research1. Increasingly, larger cohorts are
required to produce more generalisable results and distil
out trends from background error4. Diagnostic codes are a
practical method to achieve these goals1 and, therefore
they have become engrained in medical research in gen-
eral and gastroenterology research in particular4.
Pancreatitis poses a signiﬁcant burden to health sys-
tems5, at least in part because there are still obstacles to
accurate diagnosis of pancreatitis. Chronic pancreatitis
(CP) has no universally accepted diagnostic criteria6. The
Atlanta criteria to diagnose acute pancreatitis (AP) 7 offer
a composite deﬁnition that is based on the presence of
two out of the three domains (clinical, laboratory and
radiological). Each pair of domains can have different
diagnostic accuracy, and it is conceivable that individual
doctors may favour one combination over another. Fur-
ther, there is high variability in the reported positive
predictive value of diagnostic coding in AP8,9. This not
only has implications for the studies that rely on diag-
nostic coding, but also suggests possible overdiagnosing of
AP. Further, inﬂated estimates of burden of AP may lead
to excessive cost allocation, unnecessary procedures and
may deﬂate estimates of mortality10.
The aim of this study was to conduct a systematic lit-
erature review of cohort studies to assess the accuracy of
diagnostic codes for AP and CP and investigate the effect
of covariates.
Methods
Search strategy
Three electronic databases (Pubmed, EMBASE and
Scopus) were used to search for articles from the ear-
liest available date until February 1, 2016. The Pubmed
and EMBASE search strategy contained three sets of
terms and the Scopus search strategy contained four
sets. The Boolean operator 'AND' was used between
the sets whereas the operator 'OR' was used within
each set. For Pubmed, the ﬁrst set contained “Drug
prescriptions”, “Insurance, Health”, “Databases as
topic”, “Clinical coding”, “Registries”, “Hospitalisa-
tion”, “International Classiﬁcation of Disease” and
“ICD”. The second set contained “Validation Studies as
topic”, “Epidemiologic Research Design”, “Algorithm”
and “Pancreatitis/epidemiology”. The third set con-
tained “Pancreatitis”. These were all MeSH terms,
except for “ICD”. For EMBASE, the terms were sear-
ched by subject heading and exploded where possible.
The ﬁrst set contained the exploded terms of “Health
Services Research”, “Medical Records”, “International
Classiﬁcation of Disease”, “Prescriptions”, “Hospital
Discharge”, “Billing and Claims” and “Coding” and the
terms searched by keyword “Health Information”,
“Surveillance”, “Administrative Data”, “Code$” and
“ICD$”. The second set contained the exploded terms
of “Validity”, “Validation Study” and “Algorithm” and
the terms searched by keyword “Case Deﬁnition”,
“Sensitivity”, “Speciﬁcity”, “Positive Predictive Value”
and “Negative Predictive Value”. The third set con-
tained the exploded term “Pancreatitis”. For Scopus,
the ﬁrst set contained “Prescription”, “Medical
Records”, “Insurance Claim”, “Registries”, “Database”
and “Hospital Discharge”. The second set contained
“International Classiﬁcation of Disease”, “ICD*”,
“Coding” and “Code*”. The third set contained “Case
Deﬁnition”, “Sensitivity”, “Speciﬁcity”, “Positive Pre-
dictive Value” and “Negative Predictive Value”. The
fourth set contained “Acute Pancreatitis”. The search
was limited to articles in English.
Inclusion criteria
Included studies required to have reported at least one
measure of diagnostic accuracy (such as sensitivity, speciﬁ-
city, positive predictive value and negative predictive value)
in the setting of AP and/or CP. The accuracy of codes
according to either ICD-8 or ICD-9, or ICD-10 (or a com-
bination of the above) had to be compared with an inde-
pendent reference standard formulated by exper
ts in the ﬁeld. The ICD codes explored in this study were all
subtypes of K85 and K86.0, 86.1 from ICD 10 CM
and 577.0, 577.1 from ICD 8.9. Two independent reviewers
(A.Y.X.) and (M.L.T.) screened for eligible studies and any
discrepancies were discussed with the senior author (M.S.P.).
Exclusion criteria
Studies were excluded if there was inadequate infor-
mation on the coding provided or no independent refer-
ence standard used. Cases of post-ERCP pancreatitis or
postpartum pancreatitis were excluded. Studies with a
sample size of less than 25 were also excluded, as well as
studies focused on a particular aetiology of AP or CP.
Data extraction
Extraction was performed on the following variables:
type of administrative code, coding position, number of
cases identiﬁed by the administrative code, reference
standard used, number of cases veriﬁed by reference
code, positive predictive value, negative predictive
value, sensitivity and speciﬁcity. Positive predictive
value (PPV), negative predictive value, sensitivity
and speciﬁcity were calculated if not reported in
the primary article and required data were available.
Positive and negative likelihood ratios, as well
as diagnostic odds ratios, were calculated for each
study if adequate information was available. Paediatric
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and ﬁrst episode of acute pancreatitis cases were also
recorded.
Quality assessment
The QUADAS (Quality Assessment of Diagnostic
Accuracy Studies) tool11 was used to assess the metho-
dological quality of the included studies based on a total
of 14 items.
Statistical methods
For studies in which it was possible to extract infor-
mation on all four cells of the 2 × 2 table, sensitivity and
speciﬁcity were estimated with 95% conﬁdence intervals
(CI). A bivariate random-effects regression model was
ﬁtted to obtain a summary receiver operating character-
istic (SROC) curve and the corresponding area under the
curve in order to take the potential trade-off between
sensitivity and speciﬁcity explicitly into consideration and
incorporate this negative correlation into the analysis12.
Positive predictive values were calculated for all studies
included. Mean PPV was obtained using a random-effects
logistic regression. Sensitivity, speciﬁcity and PPV were
represented graphically using the corresponding forest
plots to investigate heterogeneity. Heterogeneity among
studies was quantiﬁed with the variance of the logit of
accuracy indices as estimated by the bivariate model, tau2
and I2 statistics. The minimum number of studies
required to calculate heterogeneity was two. We selected a
priori the following factors as potential sources of het-
erogeneity: ICD version, coding position, reference stan-
dard, recurrence of acute pancreatitis and age group of
the patients. If the number of studies was sufﬁcient, we
investigated heterogeneity by adding covariate terms to
the bivariate model to assess the effect of a covariate on
accuracy. Statistical analyses were conducted using the
Metandi and Metaprop_one programs for the STATA
software13.
Results
Characteristics of the included studies
A total of 24 studies were included in the ﬁnal analysis
(Fig. 1). Baseline characteristics of all the included cohorts
are shown in Table 1. A total of 21 cohorts investigated
AP8,14–33 and seven cohorts—CP15,18,20,21,34–36. In AP,
two cohorts used ICD-8, 15—ICD-9 and ﬁve—ICD-10. In
CP, two cohorts used ICD-8, ﬁve—ICD-9 and two—ICD-
10. The total number of individuals in the source popu-
lation was 18,106 (6858 with AP; 1927 with CP; 8537 with
diseases other than AP and 784 with diseases other than
CP). The total number of validated cases was 7464 (5668
with AP and 1796 with CP). The median study period was
3 years with an interquartile range of 2 to 10 years.
Methodological quality of the included studies is pre-
sented in Tables 2 and 3.
Studies in acute pancreatitis
A total of 21 cohorts reported on the PPV of ICD codes
for AP. The crude pooled PPV was 0.71 (95% CI
0.61–0.79; p < 0.0001; I2= 98.5%) (Fig. 2). Six cohorts
(10,018 participants) reported on sensitivity, speciﬁcity,
positive likelihood ratio, negative likelihood ratio and
diagnostic odds ratio. The crude pooled sensitivity and
speciﬁcity were 0.85 (95% CI 0.59–0.96) and 0.96 (95% CI
0.65–1.00), respectively (Fig. 3). The crude pooled positive
likelihood ratio, negative likelihood ratio and diagnostic
odds ratio were 21.6 (95% CI 2.1–223.7), 0.2 (95% CI
0.1–0.5) and 137.8 (95% CI 19.0–1001.4), respectively.
The SROC curve produced an area under the curve of
0.95 (95% CI 0.56–1.00) (Fig. 4).
The subgroup analysis according to the versions of ICD
included 10,809 participants from 14 cohorts that used
ICD-9 alone, as well as 2855 participants from three
cohorts that used ICD-10 alone. The PPV for ICD-9 codes
Fig. 1 Flow chart of the study selection process
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was 0.69 (95% CI 0.55–0.81; Tau2= 0.271; I2= 98.3%),
whereas the one for ICD-10 was 0.79 (95% CI 0.69–0.88;
Tau2= 0.042; p= 0.189; I2= 95.7%), p= 0.189. The sub-
group of adult patients only included 14,938 participants
from 19 cohorts and yielded a PPV of 0.71 (95% CI
0.61–0.80; Tau2= 0.207; I2= 98.4%), whereas the sub-
group of paediatric patients only included 694 partici-
pants from three cohorts and yielded a PPV of 0.68 (95%
CI 0.44–0.88; Tau2= 0.173; I2= 95.5%), p= 0.826. The
subgroup analysis according to deﬁnitions of AP showed
that studies that used the Atlanta deﬁnition as the refer-
ence standard (4163 participants from seven cohorts)
yielded a PPV of 0.79 (95% CI 0.67–0.88; Tau2= 0.123; I2
= 98.4%). The remaining 14 cohorts (10,725 participants)
used a reference standard other than the Atlanta deﬁni-
tion and yielded a PPV of 0.66 (95% CI 0.51–0.80; Tau2=
0.337; I2= 98.5%). The subgroup analysis according to
coding position included 9881 participants from seven
cohorts with primary coding position and yielded the PPV
of 0.75 (95% CI 0.59–0.88; Tau2= 0.207; p= 0.596; I2=
98.3%). The PPV for primary or secondary coding position
was 0.81 (95% CI 0.773–0.837; Tau2= 0.003; p= 0.596; I2
= 48.4%). The sensitivity analysis constrained to incident
episode of AP only was based on ﬁve cohorts (1718
patients) and yielded a PPV of 0.78 (95% CI 0.70–0.85;
Tau2= 0.033; p= 0.209; I2= 87.1%).
Studies in chronic pancreatitis
A total of seven cohorts reported on the PPV of ICD
codes for CP. The crude PPV was 0.71 (95% CI 0.54–0.85;
p < 0.0001; I2= 98.3%) (Fig. 5). The sensitivity analysis
constrained to ICD-9 version only included ﬁve cohorts
(2526 participants) and yielded a PPV of 0.67 (95% CI
0.42–0.89; Tau2= 0.320; p= 0.301; I2= 98.2%). Only two
cohorts (1123 participants) reported on sensitivity and
speciﬁcity, which yielded pooled values of 0.75 (95%
0.71–0.80) and 0.94 (95% CI 0.93–0.96), respectively.
There was an insufﬁcient number of cohorts to perform
other pre-speciﬁed analyses.
Discussion
This is the ﬁrst systematic literature review and meta-
analysis to report on pooled estimates of accuracy of the
ICD codes for identifying patients with AP and CP. The
pooled PPV for AP in the present study was 0.71. Sys-
tematic literature reviews on accuracy of ICD codes in
other acute conditions found pooled estimates of PPV to
be 0.82 in ischaemic stroke37, 0.92 in myocardial infarc-
tion38 and 0.93 in subarachnoid haemorrhage37. Similarly,
the pooled PPV for CP in the present study was 0.71.
Systematic literature reviews on accuracy of ICD codes in
other chronic conditions found pooled estimates of PPV
to be 0.87 in heart failure39 and 0.89 in depression40.
Taken together, the above ﬁndings suggest that accuracy
of ICD codes in identifying patients with AP and CP is, in
general, inferior to other acute and chronic conditions.
A series of pre-speciﬁed analyses showed that higher
PPV of ICD codes for AP is reached when ICD-10, as
opposed to ICD-9, is used; when the codes are applied to
Table 2 QUADAS analysis of the acute pancreatitis
cohorts
Study ID 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Eland et al.14 Y Y N Y Y Y Y Y Y Y N Y Y Y
Porta et al.15 Y Y U Y Y Y U Y N Y Y Y Y Y
Chwistek et al.16 Y Y Y Y Y Y Y N Y Y N Y Y Y
Floyd et al.17 Y Y N Y Y Y Y Y Y Y N Y Y Y
Quraishi et al.8 N Y Y Y Y Y Y Y Y Y N Y Y Y
Yadav et al.18 N Y Y Y Y Y Y Y Y Y Y Y Y Y
Kandula et al.19 N Y Y Y Y Y Y Y Y Y N Y Y Y
Spanier et al.20 Y Y Y Y Y Y Y Y Y Y N Y Y Y
Norjgaard et al.21 Y Y N Y Y Y Y Y Y Y N Y Y Y
Dore et al.22 N Y Y Y Y Y Y Y Y Y N Y Y Y
Omdal et al.23 Y Y Y Y Y Y Y Y Y Y N Y Y Y
Razavi et al.24 Y Y Y Y Y Y Y Y Y Y N Y Y Y
Ma et al.25 N Y Y Y Y Y Y Y Y Y N Y Y Y
Edwards et al.26 Y Y N Y Y Y Y N Y Y N Y Y Y
Shen et al.27 Y Y Y Y Y Y Y Y Y Y N Y Y Y
Saligram et al.28 Y Y Y Y Y Y Y Y Y Y N Y Y Y
Podugu et al.29 Y Y Y Y Y Y Y Y Y Y N Y Y Y
Wu et al.30 Y Y U Y Y Y U Y N Y N Y Y Y
Shinagare et al.31 Y Y Y Y Y Y Y Y Y Y N Y Y Y
Bertilsson et al.32 Y Y Y Y Y Y Y Y Y Y N Y Y Y
Yang et al.33 Y Y U Y Y Y U Y N Y N Y Y Y
Table 3 QUADAS analysis of the chronic pancreatitis
cohorts
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Porta et al.15 Y Y N N Y Y U Y Y Y Y N Y Y
Bagul et al.34 Y Y U N Y Y U Y N Y N N Y Y
Yadav et al.18 N Y Y N Y Y Y Y Y Y Y N Y Y
Spanier et al.20 Y Y Y N Y Y Y Y Y Y N N Y Y
Joergensen et al.35 N Y Y N Y Y Y Y Y Y N N Y Y
Norjgaard et al.21 Y Y Y N Y Y Y Y Y Y N N Y Y
Reddy et al.36 Y Y Y N Y Y Y Y Y Y N N Y Y
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incident episode of AP as opposed to recurrent AP and
when cases are validated with the use of Atlanta deﬁni-
tion. Speciﬁcally, the subgroup analysis according to
versions of ICD showed that ICD-10 codes yield a
10% higher PPV than that of ICD-9 codes, and this is
likely a reﬂection of improvements in diagnostic meth-
ods41. ICD-10 also requires the input of aetiology of AP24,
which would require more conﬁdence in the diagnosis. It
Fig. 2 Pooled positive predictive value of ICD codes in identifying patients with acute pancreatitis
Fig. 3 Pooled sensitivity and speciﬁcity of ICD codes in identifying patients with acute pancreatitis
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is assuring that ICD-10 is now the most commonly used
version of ICD42, and improvement of PPV of the ICD
codes for AP is expected in the future. The sensitivity
analysis limited to cases of only incident episode of AP
showed a 7% higher PPV in comparison with the overall
AP cohort. This suggests that misdiagnosis may occur
when re-admitted patients with previous pancreatitis are
assumed to have another episode of pancreatitis43. Ana-
lysis of cases validated with the use of Atlanta deﬁnition
yielded the PPV of 0.79. Although this is an improvement
in comparison with the overall estimate, it is worrying that
21% cases are diagnosed with AP when, in fact, they do
not have it. The other noteworthy ﬁnding is that the PPV
of diagnostic codes is lower in children, with a PPV of just
0.68. Of note, our study did not ﬁnd PPV of AP to be
improved in the subgroup analysis of primary coding
position (0.75) in comparison to primary or secondary
coding position (0.81). The value of PPV in primary or
secondary coding positions may be higher than that of
primary coding position alone because the diagnosis of
AP was more conﬁdently made when in conjunction with
another related diagnosis, such as cholelithiasis.
Given the generally moderate PPV values of ICD codes
for AP and CP, the main clinical implication of the pre-
sent study is that overdiagnosing of pancreatitis is fre-
quent. Patients with a previous history of AP are likely to
be re-admitted with the coding of an episode of AP
again44. This episode may be a continuation of a previous
Fig. 5 Pooled positive predictive value of ICD codes in identifying patients with chronic pancreatitis
Fig. 4 Summary receiver operating characteristic (SROC) curve of
sensitivity and speciﬁcity of ICD codes in identifying patients with acute
pancreatitis
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inadequately treated episode or it could be a different
pathology at all43. One previous code of AP predisposes a
patient to more likely receive future pancreatitis diag-
nostic codes28. Advances in serum testing have allowed
detection of more mild cases of AP, but has also led to
more overdiagnosing45. The diagnosis of early CP remains
a signiﬁcant challenge. One component of the diagnostic
criteria for CP is histology, which is often unavailable at
the time of coding46. The diagnosis, thus, becomes pre-
dominantly based on imaging modalities46.
The main immediate implication for research is that
a correction factor may need to be employed to esti-
mate accurately the real burden of pancreatitis in the
studies that used ICD codes. Leong and colleagues
suggested a formula that uses speciﬁcity and sensitivity
to give a corrected prevalence47. This formula may be
useful for correcting the prevalence of CP rather than
AP. Ley and colleagues, as well as Esposito and cole-
lagues, proposed the use of PPV itself as a correction
factor for incidence and this would be more appro-
priate for AP48,49. While development of more accurate
diagnostic codes is anticipated in the future, the pooled
PPV value of 0.71 in the present study can be used to
derive corrected incidence of AP in the existing lit-
erature. There are also other ways to improve on
accuracy of epidemiological estimates in the ﬁeld of
Pancreatology. Participants can be recruited in future
studies by searching for the unique patient rather than
for the episode28. Exclusion of patients with a previous
pancreatitis diagnosis can increase the PPV as these
cases tend to have a higher chance of a misdiagnosed
readmission28. The requirement of elevated pancreatic
enzyme levels above a three-time threshold, as sug-
gested by current guidelines, may further increase the
accuracy of ICD codes28.
The limitations of the present study need to be
acknowledged. First, the included studies came from dif-
ferent countries and from hospitals of various size, which
may have contributed to heterogeneity. Second, the vali-
dation criteria used in the primary studies were not
standardised. Third, PPV as a measure of diagnostic
accuracy is affected by disease prevalence50. Given that CP
is a much less common disease than AP, PPV for CP may
have been low due to its relatively low prevalence5. Last,
inclusion of primary studies was restricted to English, and
this may have led to a language bias.
In conclusion, the overall diagnostic accuracy of ICD
codes for pancreatitis is suboptimal. It is higher when the
codes are applied to incident episode of AP and to adults,
as well as when ICD-10 is used. The correction factor of
0.71 can be used to estimate accurately the burden of AP
in studies using administrative databases. In the future,
new diagnostic criteria may need to be developed for
patients with recurrent AP and CP.
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